Learn about Bartholin Gland Cyst, also known as Bartholin's Cyst or Bartholin's Duct Cyst. This resource provides information on diagnosis, treatment, and clinical documentation of Bartholin Gland Cysts, including relevant medical coding terms for healthcare professionals. Find details on Bartholin's Cyst symptoms, causes, and management strategies.
A fluid-filled swelling of the Bartholin's gland, located near the vaginal opening.
Painless lump near the vagina, discomfort during sex or walking, redness, swelling, and possible abscess formation.
Primary care, gynecology, urgent care, emergency room for complicated cases (e.g., abscess).
Complete code families applicable to N75.0
| Description | When to use |
|---|---|
| Fluid-filled cyst near vaginal opening. | Use for non-infected Bartholin gland cysts. Consider size and symptoms. |
| Infected Bartholin gland, causing abscess. | Use for a painful, swollen, red Bartholin gland with pus. Often bacterial infection. |
| Vaginal inflammation/infection, not specific. | Use for general vaginal inflammation or infection when a more specific diagnosis is not confirmed. |
Missing or incorrect laterality (right, left, bilateral) can impact reimbursement and data accuracy. ICD-10-CM requires specifying laterality for Bartholin gland cyst.
Distinguishing between Bartholin gland cyst (N75.1) and Bartholin gland abscess (N75.0) is crucial for accurate coding and treatment planning.
Vague documentation lacking details about size, symptoms, or associated complications may lead to coding errors and rejected claims. CDI can improve documentation clarity.
Confirm palpable, fluctuant mass at Bartholin gland (ICD-10 N75.1)
Rule out abscess with signs of infection (erythema, tenderness, fever)
Document cyst size and location (left/right)
Assess patient symptoms (pain, dyspareunia)
Patient presents with a complaint of a vulvar mass or swelling, consistent with a Bartholin gland cyst. The patient reports [symptom onset and duration, e.g., a painless lump near the vaginal opening for the past two weeks]. Examination reveals a [size and location, e.g., 2 cm, non-tender, fluctuant mass located at the 4 o'clock position of the vulva]. The Bartholin duct and gland appear [description, e.g., swollen and obstructed, without erythema or warmth]. Differential diagnoses include Bartholin duct abscess, inclusion cyst, and vulvar malignancy. Given the absence of infectious signs and symptoms such as fever, pain, or purulent drainage, the diagnosis of Bartholin gland cyst is most likely. Patient education provided on Bartholin cyst causes, symptoms, and treatment options including observation, sitz baths, and surgical intervention such as incision and drainage or marsupialization if the cyst becomes symptomatic, infected, or significantly enlarged. Follow-up recommended [timeframe, e.g., in two weeks] or sooner if symptoms worsen. ICD-10 code N75.1 (Bartholin's gland cyst) assigned. This documentation supports medical necessity for provided services and facilitates accurate medical coding and billing.
Recurrence is a common challenge in Bartholin gland cyst management. While simple drainage often provides initial relief, it carries a high recurrence rate. For minimizing recurrence, several evidence-based options exist. Marsupialization, a surgical procedure creating a permanent opening for drainage, is often preferred for recurrent cysts. Word catheter placement offers another effective approach, promoting fistula formation for ongoing drainage. In cases of recurrent infection or abscess formation, excision of the Bartholin gland may be necessary, though it's generally reserved as a last resort due to potential complications. Consider implementing a multi-faceted approach based on patient-specific factors, including cyst size, recurrence history, and patient preference. Explore how different surgical techniques and post-operative care protocols can impact recurrence rates and patient outcomes. Learn more about the latest guidelines for Bartholin gland cyst treatment.
Differentiating a Bartholin's duct cyst from other vulvar conditions requires a thorough clinical evaluation. A Bartholin's cyst typically presents as a painless, unilateral swelling at the base of the labia majora. While often asymptomatic, larger cysts can cause discomfort during intercourse or walking. Distinguishing a cyst from an abscess is crucial, as an abscess presents with erythema, tenderness, and fluctuance, indicating infection. Careful palpation can help assess for these signs. Bartholin's gland carcinoma, though rare, warrants consideration, particularly in patients over 40. Suspect malignancy if the lesion is firm, irregular, fixed, or accompanied by ulceration or bleeding. Imaging studies, such as ultrasound or MRI, can aid in differentiating these conditions, and biopsy is essential for definitive diagnosis of carcinoma. Explore how diagnostic imaging can enhance your accuracy in differentiating vulvar lesions and consider implementing a standardized evaluation protocol for all vulvar masses.
Antibiotic therapy is indicated for infected Bartholin's cysts (Bartholin's abscess), often presenting with pain, swelling, redness, and fever. Empiric antibiotic choices should consider local antimicrobial resistance patterns. Commonly recommended options include broad-spectrum antibiotics like Augmentin, doxycycline, or a combination of ceftriaxone and metronidazole for covering both aerobic and anaerobic bacteria. Culture and sensitivity testing from aspirated pus can guide targeted therapy and help combat increasing antibiotic resistance. Incision and drainage are typically the primary treatment for an abscess, with antibiotics serving as adjunctive therapy. For recurrent abscesses or persistent infection, marsupialization or gland excision may be necessary. Learn more about the latest antibiotic stewardship guidelines and explore how incorporating local resistance data can optimize antibiotic selection for Bartholin's abscess management. Consider implementing a protocol for culture and sensitivity testing to guide personalized treatment and minimize antibiotic resistance development.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.